Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets

Drug Development and Industrial Pharmacy

Volumn 38, Issue 9, 2012, Pages 1068-1076

  Roberts, Matthew ^a   Vellucci, Daniele ^a,b   Mostafa, Shabbir ^c   Miolane, Cedric ^d   Marchaud, Delphine ^d  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UK Ltd   (United Kingdom)

^d GATTEFOSSÉ SAS   (France)

Author keywords

Glyceryl behenate; Lipophilic matrix; Multi particulate dosage form; Paediatric drug delivery; Rotary press simulator; Theophylline

Indexed keywords

DIBASIC DICALCIUM PHOSPHATE; DILUENT; GLYCEROL BEHENATE; LACTOSE; PHOSPHATE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ARTICLE; COMPRESSION; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG SCREENING; FORCE; KINETICS; LIPOPHILICITY; SUSTAINED DRUG RELEASE; TABLET FORMULATION; VELOCITY;

BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; FATTY ACIDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; MECHANICAL PHENOMENA; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; PRESSURE; SOLUBILITY; TABLETS; TENSILE STRENGTH; THEOPHYLLINE;

EID: 84864440329     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.638302     Document Type: Article

References (31)

1. Kachrimanis K, Petrides M, Malamataris S. (2005). Flow rate of some pharmaceutical diluents through die-orifices relevant to mini-tableting. Int J Pharm, 303:72-80.
2. Flemming J, Mielck JB. (1995) Requirements for the production of microtablets - suitability of direct-compression excipients estimated from powder characteristics and flow-rates. Drug Dev Ind Pharm, 21:2239-2251.
3. Lennartz P, Mielck JB. (1998) Minitabletting: Improving the compactability of paracetamol powder mixtures. Int J Pharm, 173:75-85.
4. Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG. (2009). Minitablets: New modality to deliver medicines to preschool-aged children. Pediatrics, 123:e235-e238.
5. Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. (2007). Developing paediatric medicines: Identifying the needs and recognizing the challenges. J Pharm Pharmacol, 59:1043-1055.
6. Lopes CM, Sousa Lobo JM, Costa P, Pinto JF. (2006). Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release. Drug Dev Ind Pharm, 32:95-106.
7. Lopes CM, Lobo JM, Pinto JF, Costa P. (2006). Compressed minitablets as a biphasic delivery system. Int J Pharm, 323:93-100.
8. Ozyazici M, Gökçe EH, Ertan G. (2006). Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm, 63:331-339.
9. Jannin V, Bérard V, N'Diaye A, Andrès C, Pourcelot Y. (2003). Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating. Int J Pha rm, 262:39-45. Drug Development and Industrial Pharmacy
10. N'Diaye A, Jannin V, Bérard V, Andrès C, Pourcelot Y. (2003). Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: Effect of polyethylene glycol behenate on lubricant capacity. Int J Pharm, 254:263-269.
11. Barthelemy P, Laforêt JP, Farah N, Joachim J. (1999). Compritol 888 ATO: An innovative hot-melt coating agent for prolonged-release drug formulations. Eur J Pharm Biopharm, 47:87-90.
12. Faham A, Prinderre P, Farah N, Eichler KD, Kalantzis G, Joachim J. (2000). Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. Drug Dev Ind Pharm, 26:167-176.
13. Hamdani J, Moës AJ, Amighi K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int J Pharm, 245:167-177.
14. Hamdani J, Moës AJ, Amighi K. (2006). Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. Int J Pharm, 322:96-103.
15. Gu X, Fediuk DJ, Simons FE, Simons KJ. (2004). Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. Drug Dev Ind Pharm, 30:1009-1017.
16. Li FQ, Hu JH, Deng JX, Su H, Xu S, Liu JY. (2006). In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm, 324:152-157.
17. Obaidat AA, Obaidat RM. (2001). Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur J Pharm Biopharm, 52:231-235
18. Rao MR, Ranpise AA, Thanki KC, Borate SG, Parikh GN. (2009). Effect of processing and sintering on controlled release wax matrix tablets of ketorolac tromethamine. Indian J Pharm Sci, 71:538-544.
19. Zhang YE, Schwartz JB. (2000). Effect of diluents on tablet integrity and controlled drug release. Drug Dev Ind Pharm, 26:761-765.
20. Zhang YE, Schwartz JB. (2003). Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev Ind Pharm, 29:131-138.
21. Zhang YE, Tchao R, Schwartz JB. (2001). Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release. Pharm Dev Technol, 6:131-144.
22. Munday DL, Fassihi AR. (1989) Controlled release delivery: Effect of coating composition on release characteristics of mini-tablets. Int J Pharm, 52:109-114.
23. Treanor G, Roberts M, Mostafa S, Miolane C. (2010) Diluent effects on drug release from sustained-release Compritol888 ATO tablets. J Pharm Pharmacol, 62:1419-1420.
24. Munday DL. (1994) A comparison of the dissolution characteristics of theophylline from film coated granules and mini-tablets. Drug Dev Ind Pharm, 20:2369-2379.
25. Bodea M, Tomuta I, Leucuta S. (2010) Identification of critical formulation variables for obtaining metoprolol tartrate minitablets. Farmacia, 58:719-727.
26. Fujicalin-product information. Available at: http://www. fujicalin.com/product/index.php. Accessed on 06 June 2011.
27. Lactopress spray-dried product information. Available at: http:// www.domo-pharma.com/products/lactopress.aspx. Accessed on 06 June 2011.
28. Fell JT, Newton JM. (1968) The tensile strength of lactose tablets. J Pharm Pharmacol, 20:657-659.
29. Doldán C, Souto C, Concheiro A, Martínez-Pacheco R, Gómez-Amoza JL. (1995) Dicalcium phosphate dihydrate and anhydrous dicalcium phosphate for direct compression: A comparative study. Int J Pharm, 124:69-74.
30. Schlack H, Bauer-Brandl A, Schubert R, Becker D. (2001). Properties of fujicalin, a new modified anhydrous dibasic calcium phosphate for direct compression: Comparison with dicalcium phosphate dihydrate. Drug Dev Ind Pharm, 27:789-801.
31. Hamza Yel-S, Aburahma MH. (2010). Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. Drug Dev Ind Pharm, 36:337-349.